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Introduction:  In clinical practice, monitoring body composition is a critical component of 
nutritional assessment and weight management in boys with Duchene muscular dystrophy 
(DMD). We aimed to evaluate the accuracy of a simple bedside measurement tool for body 
composition, namely bioelectrical impedance analysis (BIA), in boys with DMD. 
Methods:  Measures of fat free mass (FFM) were determined using a BIA machine and 
compared against estimations obtained from a reference body composition model. 
Additionally, the use of raw impedance values were analysed using three existing predictive 
equations1-3 for the estimation of FFM.  Accuracy of BIA was assessed by comparison 
against the reference model by calculation of biases and limits of agreement.     
Results:  Body composition was measured in ten boys with DMD, mean age 9.01 ± 2.34 
years.  The BIA machine values of FFM were on average 2.3 ± 14.1 kg higher than reference 
values.  Limits of agreement (based on 95 % CI of the mean) were -7.4 to 2.9 kg.  There was 
a significant correlation between the mean FFM and difference in FFM between the BIA 
machine and the reference model (r = -0.86, p= 0.02) suggesting that the bias was not 
consistent across the range of measurements.  The most accurate predictive equation for the 
estimation of FFM using raw impedance values was Pietrobelli’s3; mean difference -0.7 kg, 
95 % limits of agreement (-3.5 to 2.0 kg). 
Conclusion: In a clinical setting, where a rapid assessment of body composition is 
advantageous, the use of raw impedance values, combined with the Pietrobelli3 equation, is 
recommended for the accurate estimation of FFM, in boys with DMD. 
 
Key words Duchenne muscular dystrophy, bioelectrical impedance, body composition, fat 
mass, fat free mass 
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INTRODUCTION 
Duchenne muscular dystrophy (DMD) is the most common of the genetically inherited 
neuromuscular diseases in males, affecting one in every 3500 live male births.4 The disease 
process follows a predictable course, altering body composition via progressive muscle 
wasting and degeneration resulting from the replacement of muscle with fat and fibrous 
tissue.5 The body composition changes observed in DMD are unique, therefore, it is vital that 
accurate and acceptable techniques to assess body composition, and body composition 
change in boys with DMD are available to clinicians which could be used to monitor disease 
progression. 
 
While laboratory based body composition methods such as hydrostatic weighing, isotope 
dilution and multi compartment models, are often more accurate, each has inherent practical 
limitations, which render them unsuitable for routine use in clinical practice. Ideally, body 
composition measurement techniques in children with chronic diseases need to be quick, non-
invasive and acceptable for repeated measures. The prediction of total body water (TBW) by 
bioelectrical impedance analysis (BIA) and in turn, body composition, is an inexpensive 
technique which has applicability across a range of chronic diseases where standard body 
composition models are inaccurate6,7. Diseases such as juvenile rheumatoid arthritis and 
crohn’s disease, in which chronic inflammation and sub clinical malnutrition combined with 
use of corticosteroids is an example where BIA with disease specific equations has proven to 
be a useful means of tracking nutritional status overtime8,9.  
  
BIA measures the impedance of the body to the flow of an alternating current.10 The intra 
cellular and extra cellular fluids offer resistance to the flow, while cell membranes act as 
capacitors and thus offer reactance to the flow. As a result, impedance can be directly related 
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to total body water (TBW).  BIA is utilised in a range of clinical conditions to routinely 
measure body composition.   Clinical trials have shown the use of BIA as a non-invasive 
diagnostic tool to evaluate nutritional status, determine the prognosis of clinical patients, and 
evaluate the influence of therapeutic agents in disease management7,11-13.    
 
Currently, there is limited information to inform and direct nutritional intervention in boys 
with DMD.  The goal of weight management in children with this chronic disease is to 
preserve FFM whilst managing excess weight gain.  However, standard anthropological 
measures such as BMI and skin fold measures provide only blunt measures and are invalid 
for use in this population14-17. Boys, who may appear ‘normal weight’ according to their 
BMI, may have significantly increased fat mass. Similarly, changes in body composition as a 
result of disease progression or therapeutic treatment may not be observed using just BMI as 
an indicator or nutritional status.  Assessment of body composition variables such as fat mass 
and FFM are consequently fundamental components of clinical management in boys with 
DMD. Furthermore, while the early introduction of corticosteroid treatment has led to 
significant improvements in physical ability and pulmonary function, side effects such as 
weight gain and changes in body composition require immediate and ongoing attention from 
clinicians. 
 
Little is known about the use of BIA and its ability to accurately assess body composition in 
boys with DMD, particularly in those who now commence steroids very early in life. 
Furthermore, the anomalous body composition changes associated with DMD may alter body 
water distributions, and consequently may negate the basic assumptions made in the BIA 
calculations.   
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As body composition in boys with DMD is of interest to clinicians and dietitians, as an 
indicator of disease progression, and / or management success, it is vital that techniques used 
to measure body composition are validated accordingly in boys with DMD. Consequently, 
the aim of this study was to evaluate the use of a clinical tools such as BIA for the estimation 
of FFM against estimations obtained from a reference three component (3C) model18.  
Additionally, the use of raw bioelectrical impedance values were analysed using three 
existing FFM predictive equations1,3,19 for the estimation of FFM in steroid treated 
ambulatory boys with DMD.  
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MATERIALS AND METHODS 
Subjects 
Ambulatory boys with DMD were recruited from two neuromuscular clinics in Australia 
(“Montrose Access” - a community centre providing therapies for boys with DMD, and the 
Children's Neuroscience Centre at the Royal Children’s Hospital, Melbourne). Diagnosis was 
defined as documentation of a deletion or duplication in the dystrophin gene, or absence of 
dystrophin on muscle biopsy, in conjunction with phenotypic evidence based on 
characteristic clinical symptoms or signs by nine years of age (i.e. proximal muscle 
weakness, waddling gait, and Gowers’ manoeuvre), an elevated serum creatine kinase, and 
ongoing difficulty with ambulation. All boys were receiving corticoid steroid treatment 
(Prednisolone™ 0.12 – 0.65 mg/kg/day or Deflazacort™ 0.83mg/kg/day). 
 
Ethics 
The experimental protocol was approved by the Royal Children’s Hospital Brisbane 
(2007/119), the Royal Children’s Hospital Melbourne (29075B), and the University of 
Queensland Human Ethics Committee (2007000797). Written informed consent was obtained 
from parents and assent from the child prior to the commencement of the study.  
 
Anthropometry 
Height was measured to the last completed millimetre using a wall-mounted stadiometer 
(Holtain Instruments Limited Crymych UK) and weight was measured to the nearest 0.05kg 
using calibrated electronic scales (Tanita BWB-600 Wedderburn Scales Australia). BMI was 
calculated as weight divided by the square of height (m). Height, weight and BMI were 
converted to Z-scores using Centers for Disease Control and Prevention reference values for 
children.20 Pubertal status was recorded by a paediatric endocrinologist as Tanner stages.21 
MA
NU
SC
RIP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
Body Composition 
Bioelectrical impedance was measured using a hand to foot multi-frequency tetrapolar device, 
(BodyStat 1500 MD; BodyStat, Isle of Man, UK) adhering to standard operating procedures 
with the subject's gender, age, height, and weight entered into the device which enables FFM 
to be directly calculated from the internal algorithm (the default equation being Houtkooper 
et al.22). FFM was further calculated directly from the impedance index (ZI) as described by 
Kushner et al.23. The ZI was then used to calculate FFM, using three different equations1-3 
that were derived from children with a similar age range as our study group (Table 1).  
 
 
3C body composition model (Reference method). 
This requires the measurement of TBW body volume (BV) and weight.  FFM can  be 
calculated by rearrangement of the Fuller equation,18 equation using BV, TBW and WT; 
                                    FFM	 = 	 (2.465	x	WT)	–	(2.220	x	BV) 	+	(0.764	x	TBW)	             (1) 
 
Where weight (WT) is in kg, and BV and TBW are in litres. 
 
 TBW: TBW was obtained from isotopic dilution24 involving two isotopes (deuterium and  
18Oxygen). A baseline urine sample was collected for the determination of the background 
isotope enrichment level. Participants were then given a weighed mixture of doubly labelled 
water (DLW) (2H2O and H218O) and spot urine samples were collected post dose after 5hrs. 
The analysis of the isotopic enrichment was determined with an Isoprime Dual Inlet Stable 
Isotope Ratio Mass Spectrometer (MassLynx 4.0i Software, Isoprime, Manchester, U.K.) 
coupled in-line with a Multiprep-Gilson autosampler. All samples were analyzed in duplicate 
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and laboratory standards were calibrated using the international suite of waters SMOW, 
SLAP and GISP. Results were reported in ‰ (delta units) relative to SMOW. The zero-time 
intercepts were used to determine the dilution space (N) at the time of the dose using the 
equation of Halliday and Miller.25   Total body water (TBW) was then calculated as the mean 
of the 2H2 and 18O dilutions spaces (2H dilution space/1.04 and 18O dilution space/1.01, 
respectively).26  
 
Body Volume: Air-displacement plethysmography measurements were performed using the 
BodPod® (Life Measurement Inc., Concord, CA, USA; software version 1.69), calibrated 
prior to each measurement27 and completed twice or until the body volume (BV) 
measurements were within 150 ml or 0.2% of each other. The average of the two successful 
measurements was taken. Raw BV was adjusted for thoracic gas volume and correction for 
isothermal-like effects of the air near the skin, surface area artefact adhering to the methods 
of Fields et al28.  
 
Statistical Analysis 
Mean, SD and range were used to describe the study sample.  Shaprio Wilk and Kolmogorov-
Smirnov tests determined distribution normality.  FFM estimates from BIA using predictive 
equations were compared with the reference method (3C) by analysis of variance (ANOVA).  
Post hoc comparisons of means were performed where appropriate using Dunnett’s post hoc 
test.  The mean (± 1.96 SD) limits of agreement for the difference between methods was 
calculated according to Bland and Altman29.  The bias was then tested for significance from 
zero by using Student’s t-test.  The consistency of the bias was assessed by calculating the 
correlation between the mean and difference of the measured values30.  Level of significance 
set at 5 % was used for all comparisons.  Results are expressed as means ± SD.  Statistical 
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computation was performed using the SPSS for Windows (Version 18.0; SPPS Inc, Chicago, 
IL.).    
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RESULTS  
Data were obtained from ten ambulatory participants, all of whom attended regular school.  
All were receiving steroids (prednisolone 0.12 mg/kg/day to 0.65 mg/kg/day) and had a 
pubertal status of stage one (according to Tanner21).  Weight and height Z scores indicated 
that the boys were short for their age, but of similar weight to the reference population, which 
was reflected in the mean BMI Z score of 1.58 ± 0.83, presented in Table 2. 
 
Mean (± SD) FFM measured by BIA (BodyStat 1500 MD) (23.7 ± 5.2 kg) was statistically 
different (assessed using paired t-tests, t = -2.72, p = 0.01) to FFM as calculated from the 3C 
reference model (21.4 ± 3.07 kg) (Table 3).  Bland-Altman analysis showed that the bias 
between methods for FFM was 2.3 ± 2.6 kg.  Limits of agreement (based on 95 % CI of the 
mean) were -7.4 to 2.94 kg.  A plot of the difference (bias) between the two methods against 
mean (± SD) FFM for the two methods is presented in Figure 1. A significant negative 
correlation (r = -0.81, p = 0.00) between the differences and means for FFM was seen.  
Percentage FM was underestimated using the BodyStat1500 MD in comparison to the 3C 
reference model (29.9 ± 7.9 kg vs.  34.2 ± 11.6 kg, respectively). 
 
Three equations were also used to estimate FFM from the measured ZI using the 
BodyStat1500 MD.  Table 4 illustrates the mean difference between the methods, 95 % 
confidence intervals, statistical significance of the bias, as well as the correlation between the 
differences and means for FFM of the two methods and its statistical significance.  No 
statistically significant bias between either of the predictive equations and the 3C reference 
model were seen.  Pietrobelli’s3 equation showed the least amount of bias between the two 
methods.  Additionally, no proportional bias between the differences and means for FFM 
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estimated from the 2003 Pietrobelli3 equation and the 3C reference model was apparent, as 
illustrated by a lack of correlation.   
 
Impedance index was significantly correlated with FFM (r = 0.88, p = 0.00) and TBW (r = 
0.93, p = 0.00) obtained from the reference method, as seen in and Figure 2 and Figure 3. 
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DISCUSSION 
Compared to complex criterion methods to evaluate body composition, BIA offers a rapid, 
non-invasive, and cheap, bedside method which can be routinely used to measure and 
monitor body composition in children.  BIA potentially, offers a more informative adjunct 
measure than standard anthropometry.  
 
The impact of early introduction of steroids has been examined in populations such as 
juvenile arthritis8,31 and Crohn’s disease32. With chronic use, glucocorticoids have known 
impacts on metabolism such as promoting energy intake (increased appetite) and storage 
(gain in FM and reduction in FFM) although the exact mechanisms of action are not fully 
elucidated. In children with chronic diseases who receive steroids the side effects such as 
weight gain may override the perceived benefits, leading to their withdrawal. A simple 
measure of body compartment change provides a tool for clinicians to monitor changes in 
body composition. 
 
This study was the first to provide an evaluation of the accuracy of BIA for the estimation of 
FFM, using a 3C model as the reference method in ambulatory boys with DMD.  The use of 
the BodyStat1500 MD for estimating body composition in boys with DMD was hindered by 
the significant proportional bias seen when examining the relationship between the mean 
FFM values and the difference in FFM values from the 3C and BIA method.  Whilst there 
was significant bias between the two methods, there was also a significant negative trend 
apparent, which indicated that the bias was not consistent across the range of FFM found in 
the participants studied here.  As FFM decreased, the BIA error in estimation increased 
(Figure 1).  These results are similar to those observed by McDonald et al.33 and could have 
significant repercussions if the BodyStat1500 MD is to be used to assess body composition in 
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boys with DMD in a clinical setting. In contrast, Mok et al.17 found that in comparison to 
deuterium dilution (reference method), BIA estimates of FM did not differ significantly to 
those obtained by the reference method, and the authors suggested that BIA should be 
considered as a viable option for estimating body composition in boys with DMD.  More 
recently, Mok et al.,34 also evaluated the use of BIA to asses change in body composition in a 
group of 26 ambulatory boys with DMD aged three to 11 years old.  Estimated FFM from 
BIA was not significantly different from the reference method at baseline (BIA: 17.8 ± 4.1 
vs. reference: 15.5 ± 3.7 kg) or at five months follow-up (BIA: 18.1 ± 3.8 vs. reference: 15.8 
± 3.6 kg). However, the different reference methods used in these studies were associated 
with limitations in accurately describing body composition in boys with DMD, which may 
have contributed to this discrepancy. 
 
Furthermore, the impedance which is an output from the BodyStat1500 MD can be utilised 
(along with height), as it is a good predictor of TBW, and hence FFM19.  Here, the use of 
three different predictive equations which incorporate ZI for the estimation of FFM were 
investigated.  These results showed that the most accurate equation for the estimation of FFM 
using ZI was the 2003 age specific equation of Pietrobelli et al.3 which was able to estimate 
FFM with negligible bias and tight confidence intervals.  There was little evidence of a 
relationship between the bias and amount of FFM (r = 0.20, ns) when using the Pietrobelli3 
equation.  Similarly, no association was seen using the De Lorenzo2 and Bedgoni1 equations; 
however, clinicians should be aware of the larger biases and wider confidence intervals 
observed when using these two equations, and note that that should not be used 
interchangeably.   
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The ZI was highly correlated (r = 0.88, p ≤ 0.05) with FFM obtained from the 3C reference 
method, as might be expected, suggesting the usefulness of the impedance method in boys 
with DMD.  With any predictive equation, its use is a function of the population in which it 
was developed.  The equations tested here were developed for healthy children, in whom the 
fundamental assumptions pertaining to the hydration and density of FFM and its internal 
compartments are valid.  Changes in the distribution of water between the intracellular and 
extracellular compartments may cause significant increases in the percentage of ECW and in 
the ICW:ECW ratio.  Moreover, the prediction of FFM by many impedance models is based 
on the assumption that the FFM is 73.2 % TBW.  This percentage is based on adult studies 
and varies with age.  Therefore, changes in the extracellular water volume may result in an 
over estimation of FFM in boys with DMD33. The use of BIA in conjunction with other 
techniques such as ultra sound imaging and electrical impedance myography, may help 
elucidate the effects of steroids on muscles and allow a better determination of FFM 
composition.   
 
The relevance of measuring FFM in boys with DMD in the clinical setting was recently 
highlighted by Vuillerot et al 35. Their longitudinal research suggested that the increase or 
maintenance of FFM in steroid treated boys with DMD was associated with halting the 
deterioration of motor function.  The authors suggested that body composition measures (in 
particularly FFM) could be a convenient outcome measure for future clinical trials assessing 
the use of therapeutic agents in boys with DMD. 
 
As obesity occurs early in the disease process, and amplifies the burden on already weakened 
muscles, close monitoring of body composition is pertinent to the management of boys with 
DMD.  As standard nutritional indexes, such as BMI, are misleading (in this population), it is 
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important that accurate, non-invasive, and rapid measures of body composition are available 
for use in clinical practice.  As with many body composition prediction equations, those used 
with BIA will be population specific.  Equations developed and validated in healthy children 
and adolescents should be applied with caution in children where body composition is 
affected by the disease process, and long term use of therapeutic agents such as 
corticosteroids. 
 
It is recognised study is not without its limitations.  Similarly to Mok et al.17 it was not 
designed to evaluate the absolute validity of the BodyStat1500 MD, or a specific BIA 
equation, but to investigate the use and limitations of BIA in boys with DMD, as a potential 
bedside tool to assess body composition in clinical practice.   
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CONCLUSION 
This study demonstrated the relative shortness, and high body fat of young steroid treated 
ambulatory boys with DMD.  It is recognised that the use of the BodyStat 1500 MD internal 
algorithm for the estimation of FFM in ambulatory boys with DMD is inadequate.  However, 
the ZI resulting from BIA could be used in the estimation of FFM when imported into the 
Pietrobelli3 equation.   
 
BIA provides a rapid, non-invasive and relatively inexpensive hand held tool to measure and 
monitor body composition in a clinical setting.  Yet, before it could be recommended to be 
used routinely in clinical practice, it is imperative that longitudinal studies be carried out to 
enable the development of a DMD population specific predictive equation for the estimation 
of FFM, at various stages of the disease progression. 
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FIGURE CAPTIONS 
Figure 1. The difference in FFM determined using predicted FFM (BodyStat 1500) and 
measured FFM (3C model) against the mean FFM using both methods. The bold line 
represents the correlation between the difference in FFM and the mean FFM from the two 
methods. 
Figure 2.  Correlation between FFM (measured by the 3C model) and the Impedance Index 
Figure 3. Correlation between TBW (measured by the 3C model) and the Impedance Index 
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TABLES 
Table 1.   Predictive equations for the estimation of fat free mass. 
Source Sex Age range (y) Equation 
Bedgoni et al1  M/F  7-13 FFM = 4.8 + 0.7 ZI 
 
De Lorenzo et al2  M/F  7-13 FFM = 2.330 + 0.588 ZI + 0.211WT 
 
Pietrobelli et al3  M 7-14 FFM = 0.6375 ZI + 5.9913 
    
ZI, Impedance Index; HT, Height (cm); WT, Weight (kg); FFM, fat free mass (kg). 
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Table 2.   Physical characteristics of boys with DMD (n = 10). 
 Mean ± SD Range 
Age (y) 9.01 ± 2.34 5.88 - 13.59 
Height (cm) 123.7 ± 6.0 116.7 - 132.9 
Height Z  score -1.30 ± 1.55 -3.52 - 1.28 
Weight (kg) 34.6 ± 9.6 22.5 - 49.2 
Weight Z  score 0.76 ± 1.27 -1.56 - 2.49 
BMI (kg/m2) 22.3 ± 5.0 15.9 - 31.4 
BMI Z  score 1.58 ± 0.83 0.23 - 2.49 
BMI, body mass index. 
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Table 3.   Body Composition estimated from 3C model and BodyStat1500. 
 3C Model BodyStat 1500 
 Mean SD Mean SD 
TBW(L) 17.0 3.4 18.0 3.8 
FFM (kg) 21.4 3.1 23.71* 5.2 
 % Fat 34.2 11.6 29.91* 7.9 
The difference in FFM determined using predicted FFM (BodyStat 1500) and measured FFM 
(3C model) against the mean FFM using both methods.   
SD, standard deviation; 3C, 3 component model; TBW, total body water;  
FFM, fat free mass. 
* Significantly different to 3C model (paired t-test).  
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Table 4.   Bland-Altman analysis of the bias between measured and predicted fat free mass. 
Source FFM 
 Bias (kg) 95%  Confidence Interval p* r# p+ 
Bedgoni et al. 1 - 1.1 -10.0,7.97 ns 0.02 ns 
De Lorenzo et al. 2 - 3.1 -2.0,8.2 ns -0.40 ns 
Pietrobelli et al.3 - 0.7 -3.5,2.0 ns 0.20 ns 
p* Two-sided p value from t-test between the two methods. 
r# Product-moment correlation coefficient between the difference and mean FFM of the two 
methods. 
p+ p value corresponding to the r values for the product-moment correlation coefficient 
between the difference and mean FFM of the two methods.  
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Figure 3. Correlation between TBW (measured by the 3C model) and the Impedance Index 
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